SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,698,000 | -71.5% | 81,223 | -56.9% | 1.61% | -20.8% |
| Q3 2018 | $9,483,000 | +110.3% | 188,341 | +149.9% | 2.04% | +129.9% |
| Q2 2018 | $4,510,000 | -63.5% | 75,352 | -72.0% | 0.89% | -64.1% |
| Q1 2018 | $12,343,000 | -2.2% | 269,504 | -14.9% | 2.47% | +16.0% |
| Q4 2017 | $12,621,000 | -9.6% | 316,706 | -5.6% | 2.13% | +4.9% |
| Q3 2017 | $13,963,000 | +39.2% | 335,659 | +44.3% | 2.03% | +49.9% |
| Q2 2017 | $10,028,000 | -34.3% | 232,664 | -52.3% | 1.35% | -33.5% |
| Q1 2017 | $15,266,000 | +19.1% | 487,717 | -3.9% | 2.04% | +18.6% |
| Q4 2016 | $12,815,000 | +42.6% | 507,507 | +11.8% | 1.72% | +24.9% |
| Q3 2016 | $8,989,000 | +53.2% | 454,002 | +57.6% | 1.38% | +35.7% |
| Q2 2016 | $5,868,000 | -5.8% | 288,092 | -29.5% | 1.01% | -5.8% |
| Q1 2016 | $6,229,000 | +52.1% | 408,479 | +34.1% | 1.08% | +21.6% |
| Q4 2015 | $4,094,000 | +159.4% | 304,603 | +170.9% | 0.88% | +56.7% |
| Q3 2015 | $1,578,000 | -13.8% | 112,455 | +4.3% | 0.56% | -8.9% |
| Q2 2015 | $1,830,000 | +567.9% | 107,778 | +375.3% | 0.62% | +190.6% |
| Q1 2015 | $274,000 | – | 22,674 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |